https://www.selleckchem.com/GSK-3.html
A retrospective, observational analysis of 47 patients with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD) enrolled at the University of Utah healthcare system was conducted. Visual acuity, neurological disability, and pain medication use were compared in relapsing versus non-relapsing patients. The median observation period was 3.6 years (range 0.0-11.4 years); the annual relapse rate was 0.1376 (95% confidence interval 0.0874, 0.191). Relapsing patients (n = 14) exhibited diminished visual acuity,
Like
Comment
Share
